Traders and Investors,

There's a huge investment opportunity unfolding right now, and it's going largely unnoticed. 

The main stream have been so focused on Canada legalizing recreational marijuana and the US legalization movement, an even BIGGER opportunity has been overlooked, Until Now.

 

The Global Cannabis Revolution

The cannabis market may have attracted some big money, but NOBODY has realized the potential of the Global weed market… except for ICC International Cannabis Corp (KNHBF), this little company is making some big moves in 16 different countries.

KNHBF is a force to be reckoned with: 35,000 pharmacies in 16 countries being represented by International Cannabis, plus a 55,000-square-foot greenhouse preparing to be constructed in cannabis-friendly Denmark. Multiple licenses for cultivation – along with a whole lot of fertile, cultivation-ready land – add up to easy expansion opportunities for this leading-edge firm.

Over the past few weeks, I've been verifying the significance of this new company trading in Canada and the U.S., which has operations in territories that I believe are not part of most people's portfolio. These are the markets of tomorrow, which we can get on board with today.

This could be, by far, the most direct opportunities in the future of cannabis sales in Europe that one could make right now.

It's so rare, to the point that this stock owns the SOLE medical-grade license for cultivation, manufacturing, distribution, and exporting of industrial hemp and CBD derived extracts, in Greece.

The commercial ramifications of this are immense. Greece is an EU-member, so setting-up shop there gives this company the ideal hub to expand into all of southern Europe.

This is only the tip of the iceberg, though, because my #1 play on multi-continental cannabis markets, ICC International Cannabis Corp. (KNHBF) has many more deals signed as well!

My #1 Cannabis Stock for tomorrow is ICC International Cannabis Corp. (KNHBF), and I'll tell you why this could potentially turn into the mother of all rallies.

The potential here is insane. First of all, the Greek government's approval just happened on the the company's license, so investors are only now wrapping their heads around the financial possibilities of it. In fact, this company, in general, has only been public for three weeks, so we're talking about an under-the-radar play, at its purest.

In Greece, the company will now be pursuing the construction of their facilities. Since Greece is part of the union, the company can EXPORT to other EU-member nations.

The EU block is twice the size of the U.S. market, so that we're clear of its immense measures and scope.

This is only one of several catalysts for KNHBF which could set them to rally like a racehorse, from today's small-cap standards of only $120M valuation.

I've probably looked at over 100 cannabis stocks in the last two years, but none offer such a wide range of opportunities in so many jurisdictions.
 

European Assets Recap

• Greek - first-to-market.

• Danavian Cannabis – a Denmark-based company, which holds one of only 12 cultivation and manufacturing licenses in Denmark.

• Global Marathon - a continental potential to distribute cannabis products to over 35,000 pharmacies, through an exclusive agreement with Cosmos Holdings!

Finished cannabis produced by ICC will be sold through Denmark's retail pharmacy network.

The Kingdom of Denmark has developed a program for reimbursement of cannabis therapeutics through its national health care program. Patients can be reimbursed for their medicinal cannabis in the same manner as all other prescriptions.

These are not even all the EU-based holdings of ICC.

In Europe International Cannabis, through its subsidiary, Danavian, controls one of twelve Danish medical cannabis cultivation and distribution licenses.

Danavian has engaged an Israeli cannabis organic cultivation and management company, Sababa Sciences Inc. Sababa Sciences will provide end-to-end management including the implementation of advanced Israeli agricultural technologies for high-quality medical cannabis treatments.
 
Danavian and Sababa Sciences have designed a 55,000-square-foot, fully automated greenhouse facility that will meet IMC-GAP, ISO:9001 and European GMP standards.
 
Finished cannabis and cannabis derivatives produced by Danavian will be sold through Denmark's retail pharmacy network.
 
This is a one-of-a-kind stock. No other company in the world has spanned the globe so vastly, efficiently, and early as ICC International Cannabis Corp. (KNHBF)!

Given the market cap of its peers, it is, in our view, potentially the deepest value stock in a properly diversified portfolio for cannabis investing idea's that one can find.

Through its subsidiaries, International Cannabis (KNHBF) has numerous agreements in place for European-based pharmaceutical distribution, wholesale importation,research and development, as well as working interests in industrial hemp licenses.

The mission of the company is simple yet powerful: to further establish itself as an international cannabis industry consolidation platform through its diversified portfolio of companies and subsidiaries. Fundamentally, what International Cannabis does is augment the design, development, and production of the world’s most innovative and best-performing cannabis products and facilities; to achieve this, the company has formulated key alliances and critical associations with top-notch companies in the space.

Currently, KNHBF is operating in regions that are ideal for the emerging legalized cannabis market. In Denmark, for instance, the company controls licenses for cannabis cultivation and manufacturing; in Greece, the firm has working interests in an industrial hemp license; and in Colombia and Africa, International Cannabis possesses licenses to cultivate, produce, distribute, store, and export cannabis and cannabis products.

Because of International Cannabis’s strategic alliances in so many locations across the globe, some truly awe-inspiring numbers have emerged:

About ICC International Cannabis Corp.

KNHBF is a force to be reckoned with: 35,000 pharmacies in 16 countries being represented by International Cannabis, plus a 55,000-square-foot greenhouse preparing to be constructed in cannabis-friendly Denmark. Multiple licenses for cultivation – along with a whole lot of fertile, cultivation-ready land – add up to easy expansion opportunities for this leading-edge firm.

I wanted to be the first to bring you the news of our latest and greatest stock pick in the global cannabis market. The modern age of legalization is more than ready for International Cannabis Corp. – a TIMELY opportunity in the cannabis space right now.
 

ICC International Cannabis Corp. (KNHBF)

 Why am I so excited about KNHBF?
 
Imagine you have the rights to sell marijuana and marijuana products to half the pharmacies in the U.S.A.
 
I don't mean half of the cannabis dispensaries.
 
I mean half of all the pharmacies - like CVS, Walgreens, and the pharmacy at your local grocery store.
 
If you had the tights to sell - do you think you'd make any money?
 
There are about 67,000 pharmacies in the United States.
 
So, half would be 33,500 pharmacies.
 
I know what you're thinking, "Marijuana isn't legal in all 50 states".
 
And you're right, it isn't.
 
Not yet.
 
But there are pharmacies outside the United States of America too.
 
...and ICC International Cannabis Corp (OTC:KNHBF | CSE:WRLD) is gobbling up distribution opportunities worldwide.
 
Consider pulling up ICC International Cannabis Corp, it's dual-listed on the OTC under (OTC: KNHBF) and the Canadian Securities Exchange under (CSE: WRLD), and the Franfurt Exchange under (8K51.F)
 
KNHBF secured the rights to distribute marijuana to about 35,000 pharmacies in 16 countries through their purchase of 50% of Marathon Global Inc., which has an exclusive agreement with Cosmos Holdings Inc., a European based pharmaceutical distributor.
 
And that is just one of the many breakthroughs moves they've made. The company is building one of the first vertically integrated global cannabis supply chains.
 
Why?
 
Because as the worldwide trend of legalizing marijuana accelerates, the industry faces a new problem.
 
Logistics.
 
There is no existing global supply chain to get cannabis from the farm to consumers around the world.
 
Until now.
 
Yet, Marijuana legalization is sweeping the globe.
 
Canada's senate passed 'the Cannabis Act' which is legalizes recreational marijuana use in October, 2018.
 
Canada's senate passed 'the Cannabis Act', in just a few short weeks (October 17th, 2018) recreational marijuana will officially become legal in Canada. In the upcoming weeks, cannabis stocks are likely to lead the entire stock market in percentage gains.
 
And that's why my focus has shifted primarily to CANADIAN Cannabis companies who are poised to capitalize tremendously off of this ONCE-IN-A-LIFETIME Event.
 
Which is why I'm confident that ICC International Cannabis Corp. (KNHBF)could become potentially one of the largest gaining cannabis plays in the entire market!
 
Germany legalized medical marijuana in 2017.
 
Colombia is undertaking a massive effort to become the world's leading exporter of marijuana.
 
African countries are starting to legalize marijuana.
 
French President Emmanuel Macron suggested he wants to change France's marijuana laws.


This is a 'booming global trend'
 
But because legalization happens on a local level there has never been a global supply chain.
 
It's a big, industry-wide problem. How do you get cannabis grown in Canada into the hands of consumers in Europe?
 
This big, industry-wide problem represents a major opportunity!
 
And it's the problem KNHBF has already started solving.
 
With the Fortune 500 piling into legal marijuana in droves, their timing looks perfect.
 
On August 15th, the maker of Corona and Modelo beers announced it had taken a 9.9 percent stake in 'the Canadian cannabis company Constellation', which can be increased to 38%.
 
The deal gives Constellation a first foothold in the cannabis infused beverage industry the brewer said it expects to soon be legalized across the United States.
 
They're not alone either. The legitimacy this deal grants to "Big Cannabis" has swung open the doors to AAA brands from a multitude of industries.
 
On August 24 th, multiple sources reported to BNN Bloomberg 'that Diageo Plc' - the world's biggest alcohol company - was pursuing a deal with a Canadian cannabis firm.
 
They are reportedly holding serious discussions with at least three major producers as they seek to add marijuana-infused beverages to their portfolio.
 
Less than a month later, Coca-Cola entered the fray - announcing talks with Aurora Cannabis to introduce drinks infused with CBD extracted from marijuana.
 
But these Fortune 500 companies still need to figure out their 'biggest problem' how to get their product to market.
 
And ICC International Cannabis Corp (OTC:KNHBF | CSE:WRLD) just might have the solution.

   
This is why there may be no better time than right now to pull up Mondays Huge New Marijuana Breakout Pick... ICC International Cannabis Corp. (KNHBF)
 
Gen. Robert H. Barrow - Commandant of the U.S. Marine Corps - once said that "amateurs talk about tactics, but professionals study logistics."
 
Logistics aren't sexy, but you can't build a $100-BIL + company without them.
 
Take Walmart. They have a $280-BIL cap. Their $500-BIL in 2017 revenues make them the 24th largest economy in the world, after Poland.
 
Why did they beat out thousands of other big box stores? They were ruthlessly efficient about optimizing their supply chains, and employing the latest technology.
 
Amazon shares the same story.
 
They weren't the only eCommerce portal online, but they were the most efficient. Jeff Bezos spent billions building and optimizing his logistics backend.
 
Amazon spent $775-MIL to buy Kiva Systems - makers of the warehouse robots that are rapidly eliminating humans from its "pack and ship" operations globally.
 
The market has rewarded Amazon with a market cap that has exceeded $1-TRIL.
 
Now ICC International Cannabis Corp (OTC:KNHBF | CSE:WRLD) is positioning itself to have the opportunity to become the 'Amazon' or 'Walmart' for 'the global marijuana supply chain.'
   
$57-BIL that's what ArcView Market Research predicts the Cannabis Industry will be worth by 2027. But, producers have to get to market first.
 
You see - marijuana isn't corn flakes or iPhones.
 
It isn't even like other regulated consumer products like alcohol or cigarettes.
The legal regime for cannabis is in flux around the world. Even in soon-to-be legal Canada, the rules will be wildly different from province to province.
 
When you add the international scene to the picture, it's even more complex.
ICC International Cannabis Corp (OTC: KNHBF | CSE:WRLD) is working to solve the problem.
 
The first asset in their distribution network is Marathon Global Inc. In June, 2018, ICC Cannabis International closed its purchase of 50% of Marathon.
 
It's their beachhead for the 742 million strong European market.
 
Through their 50% interest in Marathon, they have an exclusive agreement with Cosmos Holdings, to procure and distribute medical cannabis products and all cannabis derivatives.
 
There are over 110 clients in the Cosmos Holdings distribution network, representing approximately 35,000 pharmacies in 16 countries across Europe.
 
Their next major asset is Aricannabis BioTech Corp.
 
Aricannabis works on an exclusive basis with NuCare Health to provide Cannabis products to over 2,800 independent and corporate pharmacies across South Africa.
 
In August 2018 ICC entered into a definitive agreement to buy Aricannabis for 2,000,000 ICC shares.
 
This may the gateway to the rest of the African continent.
 
In South America they have an LOI to purchase Cannabis Medical Group SAS.
 
This Colombian entity holds licenses to cultivate, produce, hold, sell and export cannabis and cannabis derivatives - both domestically and internationally.
 
Cannabis Medical Group have acquired 13 hectares of optimal agricultural land located in Funza, the heart of the Bogota savanna, which is also one of the safest areas in Colombia.
 
Under the terms of the LOI, ICC will pay US$2.0 million to buy Cannabis Medical Group. This will gives ICC International Cannabis Corp (OTC:KNHBF | CSE:WRLD) true seed to store presence.
 
In Europe International Cannabis, through its subsidiary, Danavian, controls one of twelve Danish medical cannabis cultivation and distribution licenses.
 
Danavian has engaged an Israeli cannabis organic cultivation and management company, Sababa Sciences Inc. Sababa Sciences will provide end-to-end management including the implementation of advanced Israeli agricultural technologies for high-quality medical cannabis treatments.
 
Danavian and Sababa Sciences have designed a 55,000-square-foot, fully automated greenhouse facility that will meet IMC-GAP, ISO:9001 and European GMP standards.
 
Finished cannabis and cannabis derivatives produced by Danavian will be sold through Denmark's retail pharmacy network.

  As promised, our new stock pick is one of the most serious players in the cannabis space.

35,000 pharmacies in 16 countries are being represented by International Cannabis Corp. (CSE: WLRD & US: KNHBF), plus a 55,000-square-foot greenhouse is preparing to be constructed in cannabis-friendly Denmark. Multiple licenses for cultivation – along with a whole lot of fertile, cultivation-ready land – add up to easy expansion opportunities for this leading-edge firm.

International Cannabis is currently operating in regions that are ideal for the emerging legalized cannabis market. In Denmark, for instance, the company controls licenses for cannabis cultivation and manufacturing; in Greece, the firm has working interests in an industrial hemp license; and in Colombia and Africa, International Cannabis possesses licenses to cultivate, produce, distribute, store, and export cannabis and cannabis products.

Here is a list of their current holdings…

Marathon Global, EU Cannabis Corp., Danavian Cannabis Ltd., CanAfrica Holdings, Aricannabis, Canna Colombia Holdings, and BIOCANNA.

​I can see this potentially becoming the Canopy Growth of Europe and Africa.

How Long Will the Market Ignore This Opportunity?

Right now ICC has a market cap of just $64-MIL.
 
It's a fraction of the size of the major growers - like Canopy Growth ($14.7B).
 
But, investors are starting to "clue in" to marijuana's distribution problem.
 
And, KNHBF could be one of the biggest winners as the industry matures.

If you're interested in opportunities in the growing global cannabis markets then perhaps you should consider looking at ICC International Cannabis Corp(KNHBF).

All the best.

SmallCapMomo.com

Remember our key trading rules when trading. Capital preservation is key. Keep your stops tight, and if things don't go your way, cut your losses and look for another opportunity.